OCS
NASDAQ · Pharmaceuticals
Oculis Holding Ag
$25.10
+0.58 (+2.37%)
Open$24.80
Previous Close$24.52
Day High$25.10
Day Low$24.79
52W High$29.36
52W Low$14.00
Volume—
Avg Volume314.8K
Market Cap1.63B
P/E Ratio—
EPS$-2.17
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+8.8% upside
Current
$25.10
$25.10
Target
$27.31
$27.31
$14.95
$27.31 avg
$37.18
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 335.81M | 321.14M | 281.93M |
| Net Income | 75.81M | 72.36M | 63.56M |
| Profit Margin | 22.6% | 22.5% | 22.5% |
| EBITDA | 137.16M | 117.64M | 104.92M |
| Free Cash Flow | 80.35M | 48.21M | 59.98M |
| Rev Growth | +1.2% | -6.4% | +18.4% |
| Debt/Equity | 0.56 | 0.65 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |